Citigroup’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-252,000
Closed -$6.48M 7629
2018
Q4
$6.48M Buy
252,000
+251,000
+25,100% +$8.69M 0.01% 1605
2018
Q3
$35K Buy
1,000
+100
+11% +$3.98K ﹤0.01% 6790
2018
Q2
$37K Sell
900
-800
-47% -$32.3K ﹤0.01% 6502
2018
Q1
$67K Buy
1,700
+1,000
+143% +$36.7K ﹤0.01% 5950
2017
Q4
$23K Sell
700
-2,200
-76% -$76.2K ﹤0.01% 6655
2017
Q3
$139K Buy
2,900
+200
+7% +$9.75K ﹤0.01% 5291
2017
Q2
$133K Buy
2,700
+1,700
+170% +$75.3K ﹤0.01% 5117
2017
Q1
$44K Sell
1,000
-1,600
-62% -$64.9K ﹤0.01% 5773
2016
Q4
$86K Sell
2,600
-3,300
-56% -$128K ﹤0.01% 5859
2016
Q3
$292K Buy
+5,900
New +$307K ﹤0.01% 4367

Other funds holding ACHC

Citigroup's ACHC Position: Q1 2026 in Review

Citigroup reduced its Acadia Healthcare (ACHC) stake by 8.6% in Q1 2026, selling an estimated $4.03M and leaving 2,352,318 shares worth $55M. The position accounts for 0.02% of the portfolio, ranked #608.

Citigroup first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $72M in Q1 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Citigroup held 2,352,318 shares of Acadia Healthcare worth $55M as of Q1 2026.
  • Citigroup sold 222,622 Acadia Healthcare shares in Q1 2026, an estimated $4.03M.
  • Acadia Healthcare made up 0.02% of Citigroup's portfolio in Q1 2026, its #608 holding.
  • Citigroup first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Acadia Healthcare position peaked at $72M in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.